Rometty Lisa Ann 4

4 · Rani Therapeutics Holdings, Inc. · Filed Dec 17, 2024

Form 4

Period: 2024-12-16

Director

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2024-12-16−101,276→ 0 total
Exercise: $2.84From: 2024-05-25Exp: 2033-05-24→ Class A Common Stock (101,276 underlying)
Award
Stock Option (Right to Buy)
2024-12-16+17,708→ 49,037 total
Exercise: $9.44Exp: 2032-01-02→ Class A Common Stock (17,708 underlying)
Award
Stock Option (Right to Buy)
2024-12-16+101,276→ 101,276 total
Exercise: $4.11From: 2024-05-25Exp: 2033-05-24→ Class A Common Stock (101,276 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2024-12-16−17,708→ 0 total
Exercise: $2.84Exp: 2032-01-02→ Class A Common Stock (17,708 underlying)

Footnotes (3)

[F1]On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.
[F2]The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years.
[F3]On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options.

Documents

1 file